SB
This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.
Updated 19 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BIFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.